Highest-materiality recent filing
Bonk appoints founder Mitchell Rudy as President; targets 5% BONK ownership
Mitchell Rudy (Nom) appointed President effective April 27, 2026; will remain on Board.
Bonk Inc. appoints Chris Melton as Chairman of the Board
Appointment effective April 22, 2026; no prior arrangements or understandings with any person.
Bonk, Inc. Executive Chairman John Gulyas resigns effective Jan 12, 2026
John Gulyas resigned as Executive Chairman and board member effective January 12, 2026.
Bonk President Jordan Schur resigns effective Dec 29, 2025
Jordan Schur resigned as President of Bonk, Inc., effective December 29, 2025.
Bonk, Inc. reports annual meeting results; all director nominees and auditor ratification approved
Seven directors re-elected with over 136M votes for each; highest abstain was 604,697 for Connor Klein.
Bonk, Inc. effects 1-for-35 reverse stock split effective December 11, 2025
Reverse stock split at 1-for-35, effective 12:01 a.m. ET on December 11, 2025.
Bonk, Inc. acquires 51% revenue interest in Bonk.fun, implied valuation ~$30M, no cash or dilution
Acquired additional 41% revenue interest in Bonk.fun, raising total to 51% majority stake.
Bonk, Inc. shareholders authorize 4x increase in common stock to 1B shares from 250M
Special meeting on Oct 31, 2025 approved amendment to increase authorized shares from 250M to 1B.
Bonk appoints three directors, gains Bonk-aligned board majority; Nasdaq compliance matter closed
Board adds Connor Klein (New Form Capital), Stacey Duffy (financial due diligence), Jamie McAvity (Cormint CEO); Schur and Pascucci resign.
Bonk stockholders approve share increase to 1B and dilutive issuances
Proposal to increase authorized common shares from 250M to 1B passed (69.4M for, 11.9M against).
Bonk, Inc. clarifies PIPE share issuance pending shareholder approval in 8-K/A
PIPE of 51,921,080 shares at $0.4815/share for $25M in BONK tokens not issued; requires shareholder approval.
Safety Shot rebrands as Bonk, Inc., ticker changes to BNKK; abandons Caring Brands spin-off
Name change to Bonk, Inc. and symbol change to BNKK effective Oct 10, 2025 on Nasdaq.
Safety Shot signs employment agreement with CFO Markita Russell; $250k base plus equity awards
Employment agreement dated Oct 3, 2025, retroactive effective June 30, 2025.
Safety Shot appoints BONK co-founder Rudy to board; issues 176M+ shares for BONK tokens
Mitchell Rudy (Nom), BONK core founder, appointed to Safety Shot board on Sept 5, 2025, replacing Dave Long.
Safety Shot COO David Sandler resigns, stays as consultant for six months
David Sandler resigned as COO effective August 29, 2025.
Safety Shot raises ~$29.25M via RD offering ($4.25M cash) and PIPE ($25M in BONK tokens)
RD Offering: 9,239,044 shares at $0.46/share for ~$4.25M cash.
Safety Shot amends Series C Preferred conversion price to $1.081, reducing potential dilution
Conversion price raised from $0.5582 to $1.081 based on 5-day average closing price before August 9, 2025.
Safety Shot issues preferred shares for $25M in BONK tokens and 10% revenue share of BONK.fun
Issued 35,000 Series C Preferred shares for $25M in BONK tokens (convertible at $0.5582 per share).
CFO Danielle De Rosa resigns; settlement includes 425K shares, 200K options accelerated, $300K cash
CFO Danielle De Rosa resigned effective July 25, 2025; settlement agreement dated July 25, effective August 2.
Safety Shot appoints Markita Russell as CFO after Danielle De Rosa resigns
Danielle De Rosa resigned as CFO effective July 25, 2025; no reason given.
Safety Shot raises $16.3M via registered direct offering and warrants
Issued 22,993,492 shares at $0.461/share and warrants to purchase up to 45,986,984 shares at $0.461.
Safety Shot sells 500,000 SRM Entertainment shares for $2.5M
Sold 500,000 shares of SRM Entertainment common stock for $2,500,000 cash to an institutional investor.
Safety Shot sells 500K SRM shares for $3.125M; Nasdaq gives bid-price extension to Dec 29, 2025
Sold 500,000 shares of SRM Entertainment common stock for aggregate $3,125,000 in cash.
Safety Shot exchanges $5.25M convertible notes for Series B Preferred; warrant strike cut to $0.33
Exchanged $1.75M secured note (Dec 2026) and $3.5M note (Jul 2025) for 7,212 Series B Preferred shares, $750 stated value each.
Safety Shot (SHOT) raises $250k via PIPE at $0.296/sh, 20% discount
844,594 shares sold at $0.296/share, a 20% discount to July 3 closing price.
Safety Shot raises $250K in PIPE at $0.25/sh, cancels 6.6M shares
Entered Securities Purchase Agreement for 1M shares at $0.25 each (20% discount), gross proceeds $250K.
Safety Shot reports SRM investment value jumps from $1M to $18.2M as of June 30, 2025
Held 2,347,142 shares of SRM common stock valued at $7.75/share ($18.2M total) as of June 30, 2025.
Safety Shot closes acquisition of Yerbaé; issues 19.9M shares, assumes $3.8M debentures
Closed acquisition of Yerbaé Brands on June 27, 2025; Yerbaé shareholders received 0.2918 SHOT shares per share, total 19,881,948 shares issued.
Safety Shot issues 7.3M shares to settle $1.46M debt; raises $250K via PIPE at $0.216/share
Issued 7,275,915 shares to Silverback Capital to settle $1,461,800 in liabilities under Section 3(a)(10).
Safety Shot delays closing of Yerbaé acquisition to next week after shareholder approval
Acquisition of Yerbaé Brands Corp. approved by majority of Yerbaé stockholders on June 12, 2025.
Proposal 1: Issuance of shares to Yerbaé shareholders approved (20.4M for, 2.3M against, 20M broker non-votes).
Safety Shot shareholders approve acquisition of Yerbaé; close expected next week
Shareholders voted majority approval at special meeting to acquire Yerbaé Brands Corp.
Safety Shot amends liabilities settlement program; 1M shares issued for fees
Court approved the liabilities settlement program on May 20, 2025.
Safety Shot expands R&D into nootropics and sleep aids leveraging Sure Shot technology
Company initiating R&D for nootropic and sleep aid product lines, leveraging Sure Shot technology.
Annual meeting June 12, 2025; record date April 28; virtual-only format.
Yerbaé (SHOT acquisition partner) partners with Guckenheimer for 480+ corporate café locations
Guckenheimer operates 480+ market and café locations across 34 states, serving Google, Texas Instruments, Duolingo.
Safety Shot settles $14.58M in liabilities via equity issuance to Silverback Capital
Court approved May 20, 2025; company to issue freely trading shares under Section 3(a)(10) to settle $14,580,395.73 in liabilities.
Safety Shot expects 1000% revenue increase in 2025 over 2024 after Yerbae acquisition
Safety Shot expects 2025 annual revenue to increase 1000% over 2024 following the Yerbae acquisition.
Safety Shot issues 641,000 shares in $250k PIPE at $0.39/share
Raised $250,000 gross via PIPE sale of 641,000 shares at $0.39 per share to one accredited investor.
Safety Shot issues $75M Series A Preferred to Core 4 in exchange for common, warrants, RSUs
Exchanged 7,700,014 common shares for 46,765 Series A-1 Preferred shares (stated value $750 each).
Safety Shot extends Core 4 consulting deal, sells 4M warrants for $500K
Consulting agreement extended to April 1, 2026; additional 2,500,000 restricted shares issued, vesting quarterly.
Safety Shot amends Bigger Capital settlement; defers $3.5M note conversion to July 21, 2025
Bigger Capital agrees not to convert $3.5M convertible note before July 21, 2025.
Safety Shot business update: Yerbae acquisition, Caring Brands spin-off, clinical trial results
Acquiring Yerbae, a plant-based energy drink backed by athletes; shareholder vote targeted for late May/June 2025.
Safety Shot raises $1.288M via PIPE at $0.368 per share
Sold 3,500,000 shares of common stock at $0.368 per share for gross proceeds of $1,288,000.
Safety Shot publishes peer-reviewed trial showing rapid alcohol reduction and hangover prevention
Randomized, double-blind, placebo-controlled crossover study published in Journal of Nutrition and Dietary Supplements (Volume 17, Pages 43-62).
Safety Shot appoints CORE IR & PR for investor relations and PR services
Appoints CORE IR & PR to assist with investor relations, shareholder communications, and public relations.
Safety Shot raises $1.0M via registered direct offering of 2.2M shares at $0.45/share
Gross proceeds of $1,000,000 from sale of 2,222,222 shares at $0.45 per share.
Safety Shot and Yerbaé CEOs to discuss market disruption in Feb 25 webinar
Webinar scheduled for Feb 25, 2025 at 12:00 PM ET with CEOs Jarrett Boon (SHOT) and Todd Gibson (Yerbaé).
Safety Shot raises $1.17M in PIPE, issues 2.75M shares and warrants
Gross proceeds of $1,165,198 from sale of 2,753,304 shares at $0.3632/share and 2,753,304 warrants.
Safety Shot secures order for 150 cases of Sure Shot from Midwestern grocer with 285+ stores
Order from a prominent Midwestern grocery chain with over 285 stores across eight states.
On April 27, 2026 the board of directors (the “ Board ”) of Bonk, Inc. (the “ Company ”) appointed Mitchell Rudy to serve as President of the Company, effective immediately.
the board of directors (the “ Board ”) of Bonk, Inc. (the “ Company ”) appointed Chris Melton as the Company’s Chairman of the Board effective immediately.
On March 25, 2024, the board of directors (the “Board”) of the Company appointed David Sandler as the Chief Operating Officer of the Company.
On March 13, 2024, the board of directors (the “Board”) of Safety Shot, Inc. (the “Company”) appointed Jordan Schur as a member to the Board, and as the President of the Company.
On March 8, 2024, the Board the Company appointed David Long as a member of the Board.
On March 13, 2024, the board of directors (the “Board”) of Safety Shot, Inc. (the “Company”) appointed Jordan Schur as a member to the Board, and as the President of the Company.
On February 28, 2024, Mr. John resigned from the Board.
On February 28, 2024, Markita L. Russell resigned from her position as the Chief Financial Officer of the Company, effective February 29, 2024.
On February 27, 2024, the board of directors (the “Board”) appointed Danielle De Rosa as the Chief Financial Officer of the Company, effective March 1, 2024.
On February 28, 2024, Brian S. John resigned from his position as the Chief Executive Officer of the Company, effective immediately.
the shareholders voted against the re-election of Dr. Hector Alila. As a result, Dr. Alila was removed from his position as a member of the board of directors (the “Board”), effective December 6, 2023.
the Board appointed Richard Pascucci as a member of the Board to fill in the vacancy created by the removal of Mr. Alila.
Max materiality 0.90 · Median 0.60 · Most common event other_material